Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.

Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators.

Thromb Haemost. 2012 Feb;107(2):280-7. doi: 10.1160/TH11-07-0464. Epub 2011 Dec 21.

PMID:
22186771
[PubMed - indexed for MEDLINE]
2.

Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.

Bergqvist D, Arcelus JI, Felicissimo P; ETHOS investigators.

Thromb Haemost. 2012 Feb;107(2):270-9. doi: 10.1160/TH11-07-0463. Epub 2011 Dec 21.

PMID:
22186708
[PubMed - indexed for MEDLINE]
3.

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.

Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ; RE-NOVATE II Study Group.

Thromb Haemost. 2011 Apr;105(4):721-9. doi: 10.1160/TH10-10-0679. Epub 2011 Jan 12.

PMID:
21225098
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk